Navigation Links
RNAi: Size Does Matter


Everyone wants to design the dsRNA that most efficiently silences the gene of interest. But how does dsRNA length correlate with silencing efficiency? Ambion scientists addressed this question in the
following experiment.

dsRNA of different sizes and directed against different regions of hrp48 and U2AF50 cDNA (Figure 1A), were prepared using the MEGAscript RNAi Kit and tested on Drosophila L2 cells. For both targeted genes, Western blot analyses showed a stronger silencing effect with dsRNA corresponding to the full length cDNA than with shorter dsRNAs (Figure 1B and D). Similar reduced activities (in comparison to that of full length dsRNAs) were obtained with shorter dsRNA specific for either the 5' or the 3' end of U2AF50 cDNA (Figure 1B).

Interestingly, the high level of silencing induced by the longer dsRNAs could be reached with the shorter dsRNAs by increasing the concentration of the shorter dsRNAs 2-3 fold (Figure 1D). Because yields of dsRNA synthesized and purified with the MEGAscript RNAi Kit are reproducibly higher for shorter dsRNA (Figure 1C), two to five time more experiments can be performed per transcription reaction with 300 to 600 nt long dsRNA. Therefore, it may be more convenient and cost effective to perform silencing experiments with the higher concentration of shorter dsRNA.

Figure 1. Correlation Between dsRNA Size, Transcription Yield and Silencing Effect. (A) Schematic representation of the various dsRNA used in this study. (B) Western blot ana lysis 72 hours post treatment with 10 nM of the indicated dsRNA. (C) Yields of dsRNA synthesized and purified with the MEGAscript RNAi kit using 0.4 g of PCR DNA templates containing T7 RNA polymerase promoters on both ends. (D) Western blot analysis 72 hr post treatment with different concentrations of the indicated dsRNA.


back to top


Ordering Information
Cat# Product Name Size 1626 MEGAscript RNAi Kit 20 rxns
'"/>

Source:


Page: All 1 2

Related biology technology :

1. RNAi: A How To for New Users
2. RNAi: Get the Whole Story
3. RNAi: The Controls You Need
4. siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005)
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/27/2017)... RESEARCH TRIANGLE PARK, N.C. , April 27, 2017 ... ) today announced that its Board of Directors authorized ... company,s common stock. This program will became effective immediately, ... may be made in the open market, accelerated share ... time as determined by United Therapeutics, management and in ...
(Date:4/27/2017)... ... April 27, 2017 , ... Arrowhead Publishers is pleased ... is coming to San Diego, CA on September 27-28, 2017. Leaders from the ... latest advances in the treatment of various types of pain. There are also ...
(Date:4/27/2017)... ... April 27, 2017 , ... The Council for Agricultural ... to Jayson Lusk, a consummate communicator who promotes agricultural science and technology in ... as he explains how innovation and growth in agriculture are critical for food ...
(Date:4/26/2017)... Alto, CA, USA (PRWEB) , ... April 26, ... ... popular seminar on FDA’s GMP expectations for phase I clinical trials comes to ... attended by various biotechnology and pharma professionals representing FDA regulated organizations such as ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 Research and Markets has announced ... report to their offering. ... global eye tracking market to grow at a CAGR of 30.37% ... Tracking Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/5/2017)... SEATTLE , April 5, 2017  The Allen ... the Allen Cell Explorer: a one-of-a-kind portal and dynamic ... large-scale 3D imaging data, the first application of deep ... edited human stem cell lines and a growing suite ... the platform for these and future publicly available resources ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
Breaking Biology News(10 mins):